Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
St. Jude Medical reports net sales of $1.422 billion in fourth quarter 2013

St. Jude Medical reports net sales of $1.422 billion in fourth quarter 2013

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

Study shows that anticoagulant medicine appears to protect patients against stroke

Study shows that anticoagulant medicine appears to protect patients against stroke

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Porter Adventist Hospital first in Colorado to receive full Atrial Fibrillation Certification status from SCPC

Porter Adventist Hospital first in Colorado to receive full Atrial Fibrillation Certification status from SCPC

iRhythm Technologies’ ZIO Service detects more cardiac arrhythmias than Holter monitor

iRhythm Technologies’ ZIO Service detects more cardiac arrhythmias than Holter monitor

STSI researchers develop a small wireless device that detects abnormal, dangerous heart rhythms

STSI researchers develop a small wireless device that detects abnormal, dangerous heart rhythms

AtriCure completes previously announced acquisition of Endoscopic Technologies

AtriCure completes previously announced acquisition of Endoscopic Technologies

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

ESC presents results of pilot registry on management and treatment of AF in Europe

ESC presents results of pilot registry on management and treatment of AF in Europe

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Study identifies atrial fibrillation as a growing and serious global health problem

Study identifies atrial fibrillation as a growing and serious global health problem

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Long-term ECG may help patients suffering from chronic cardiac insufficiency

Long-term ECG may help patients suffering from chronic cardiac insufficiency

FDA accepts ARCA biopharma's Gencaro IND application for atrial fibrillation

FDA accepts ARCA biopharma's Gencaro IND application for atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.